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Summary
Background The London Summit on Family Planning in 2012 inspired the Family Planning 2020 (FP2020) initiative 
and the 120 × 20 goal of having an additional 120 million women and adolescent girls become users of modern 
contraceptives in 69 of the world’s poorest countries by the year 2020. Working towards achieving 120 × 20 is crucial 
for ultimately achieving the Sustainable Development Goals of universal access and satisfying demand for reproductive 
health. Thus, a performance assessment is required to determine countries’ progress.
Methods An updated version of the Family Planning Estimation Tool (FPET) was used to construct estimates and 
projections of the modern contraceptive prevalence rate (mCPR), unmet need for, and demand satisfied with modern 
methods of contraception among women of reproductive age who are married or in a union in the focus countries of 
the FP2020 initiative. We assessed current levels of family planning indicators and changes between 2012 and 2017. 
A counterfactual analysis was used to assess if recent levels of mCPR exceeded pre-FP2020 expectations.
Findings In 2017, the mCPR among women of reproductive age who are married or in a union in the FP2020 focus 
countries was 45·7% (95% uncertainty interval [UI] 42·4–49·1), unmet need for modern methods was 21·6% 
(19·7–23·9), and the demand satisfied with modern methods was 67·9% (64·4–71·1). Between 2012 and 2017 the 
number of women of reproductive age who are married or in a union who use modern methods increased by 28·8 million 
(95% UI 5·8–52·5). At the regional level, Asia has seen the mCPR among women of reproductive age who are married 
or in a union grow from 51·0% (95% UI 48·5–53·4) to 51·8% (47·3–56·5) between 2012 and 2017, which is slow growth, 
particularly when compared with a change from 23·9% (22·9–25·0) to 28·5% (26·8–30·2) across Africa. At the country 
level, based on a counterfactual analysis, we found that 61% of the countries that have made a commitment to FP2020 
exceeded pre-FP2020 expectations for modern contraceptive use. Country success stories include rapid increases in 
Kenya, Mozambique, Malawi, Lesotho, Sierra Leone, Liberia, and Chad relative to what was expected in 2012.
Interpretation Whereas the estimate of additional users up to 2017 for women of reproductive age who are married or 
in a union would suggest that the 120 × 20 goal for all women is overly ambitious, the aggregate outcomes mask the 
diversity in progress at the country level. We identified countries with accelerated progress, that provide inspiration 
and guidance on how to increase the use of family planning and inform future efforts, especially in countries where 
progress has been poor.
Funding The Bill & Melinda Gates Foundation, through grant support to the University of Massachusetts Amherst 
and Avenir Health.
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Introduction
The international community has agreed that the right to 
health includes the right to control one’s health and body, 
including sexual and reproductive freedom.1 The Family 
Planning 2020 (FP2020) initiative is a global movement 
that supports this right and therefore the rights of women 
and girls to decide freely and for themselves whether, 
when, and how many children they want to have. The 
initiative is an outcome of the 2012 London Summit 
on Family Planning where more than 20 national 
governments made commitments to address the 
policy, financing, delivery, and sociocultural barriers to 
women accessing contraceptive information, services, and 
supplies, and donors pledged US$2·6 billion in funding.2 
The overall goal of FP2020 is to reach 120 million 
additional users of modern contraceptive methods in the 
world’s poorest countries by 2020 (the 120 × 20 goal).3 
Working towards the goal is crucial to meeting Sustainable 
Development Goals (SDGs) related to health (Goal 3)4 and 
gender equality and women’s empowerment (Goal 5).4
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Progress towards achieving the 120 × 20 goal is 
monitored by the Track20 project.5 Track20 engages at the 
country level helping to develop effective programme 
strategies and plans. In particular, the project implements 
annual monitoring and evaluation workshops, which 
support national efforts to collect, analyse, and use data to 
track family planning progress, relying mainly on 
modelling applications such as the Family Planning 
Estimation Tool6 (FPET). FPET is a web application that 
uses historical survey data and family planning service 
data to produce estimates and projections of family 
planning indicators over time, used currently for women 
who are married or in a union of reproductive age. FPET 
is a country-specific (local) implementation (appendix p 17) 
of the global family planning estimation model7 used by 
the UN Population Division.
In this study, we update the global family planning 
estimation model and subsequently the FPET tool and use 
it to evaluate the performance of 68 out of the 69 countries 
involved in the FP2020 initiative. Western Sahara, which 
has no data, was omitted from the analysis, as it was not 
included in the Track20 reporting for the initiative. 
Analysis includes the assessment of four core family 
planning indicators: the modern contraceptive prevalence 
rate (mCPR); the number of additional women married or 
in a union of reproductive age who are users of modern 
methods of contraception; the percentage of women with 
an unmet need for modern methods of contraception; and 
the percentage of women with their demand for 
contraception satisfied with a modern method.
Methods
Definitions and data sources
Modern methods of contraception include female and 
male sterilisation, oral hormonal pills, the intra-uterine 
device, male and female condoms, injectables, the 
implant (including Norplant; Wyeth-Ayerst, Collegeville, 
PA, USA), vaginal barrier methods, standard days 
method, lactational amenorrhoea method, and emergency 
contraception. Traditional methods of contraception 
include abstinence, the withdrawal method, the rhythm 
method, douching, and folk methods.
Contraceptive prevalence was measured as the 
percentage of women who report themselves or their 
partners as currently using at least one contraceptive 
method of any type (modern or traditional). Unmet need 
for family planning was defined as the percentage of 
women who want to stop or delay childbearing but who 
are not currently using any method of contraception to 
prevent pregnancy. Observations of unmet need for 
family planning in our database were, whenever possible, 
based on the revised algorithm of the indicator designed 
to improve comparability within and across countries.8 
The estimates reported in this study are for women of 
reproductive age (15–49 years) who are currently married 
or in a union. With the exception of India, the FP2020 
country data uses the UN Population Division data-
base for contraceptive prevalence and unmet need for 
family planning9 as a base (appendix p 4). These data 
were obtained from nationally representative household 
surveys, the Demographic and Health Surveys (DHS), 
Performance Monitoring and Accountability 2020 
(PMA2020) surveys, the Multiple Indicator Cluster 
Surveys, and the Reproductive Health Surveys. In 
India, state-level data for family planning indicators 
were obtained from multiple rounds of the DHS (also 
known as the National Family Health Survey [NFHS]), 
the District Level Household and Facility Survey, and 
the Annual Health Survey (appendix p 6). In some 
countries, survey data for modern contraceptive use are 
Research in context
Evidence before this study
Estimates of family planning indicators are produced annually 
by the UN Population Division and by the Track20 project. Both 
sets of estimates are based on the family planning estimation 
model (FPEM). Track20 supports national efforts to collect, 
analyse, and use existing data to track annual progress in 
family planning for the Family Planning 2020 (FP2020) 
initiative. The previous FP2020 publication included estimates 
up to the year 2016.
Added value of this study
In this study, we evaluate progress in family planning 
indicators in the focus countries of the FP2020 initiative 
between 2012 and 2017 using an updated database, including 
data obtained from Track20 annual monitoring and 
evaluation workshops, and an updated version of the FPEM. 
The updated FPEM is better equipped to capture recent 
changes (ie, changes that occur between the two most recent 
observations) in contraceptive prevalence and includes 
additional survey-specific information (uncertainty estimates 
and reference periods). Our study presents a counterfactual 
analysis to distinguish countries that have made the best or 
worst progress relative to pre-FP2020 expectations. 
The comparison of estimates for the current modern 
contraceptive prevalence rate (mCPR) with counterfactual 
projections reflecting expectations for mCPR at the beginning 
of FP2020, shows that, overall, more than half of the 
countries with data after 2012 exceeded pre-FP2020 
expectations to some degree. Kenya and Mozambique are 
highlighted as making the most progress in terms of 
increasing modern contraceptive use.
Implications of all the available evidence
Family planning programmes need to focus on areas where 
progress is lacking. Countries, such as Kenya, that have made the 
most progress in terms of increasing mCPR and decreasing unmet 
need can provide case studies for achieving success in other 
countries.
See Online for appendix
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Figure 1: 2017 estimates for 
family planning indicators
Median estimates of 
(A) modern contraceptive 
prevalence, (B) unmet need 
for, and (C) demand satisfied 
with modern methods in 2017 
for 68 Family Planning 
2020 countries.
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supplemented with family planning service data10 (service 
statistics; appendix pp 7, 18–21) that have been obtained 
through Track20 monitoring and evaluation workshops. 
The estimates presented in this report are based on 
733 survey observations of contraceptive prevalence 
between 1969 and 2017 from 67 countries and 32 Indian 
states, and 462 survey observations of unmet need for 
family planning from 64 countries and 32 Indian states. 
Additionally, 85 service statistic observations for esti-
mated modern contraceptive use are included in the 
database for 13 countries.
The family planning estimation model
The family planning estimation model combines a 
Bayesian hierarchical model with country-specific time 
trends to yield estimates of contraceptive prevalence 
and unmet need for family planning for women of 
reproductive age who are married or in a union 
aged 15–49 years. The model accounts for differences by 
data source, sample population, and contraceptive 
methods included in the measure.7 For every country, the 
family planning estimation model models contraceptive 
prevalence with an expected trend that assumes 
contraceptive prevalence will begin with a gradual 
increase, the increase will subsequently become more 
rapid, and then it will begin to slow down when high 
levels of prevalence are reached. The parameters that 
control the trend are estimated hierarchically, such that 
estimates are based on the data available in the country 
of interest, and also the sub-regional, regional, and global 
experience. Distortions are added to capture how the 
level of the observed data deviates from the level of the 
expected trend, producing estimates of contraceptive 
prevalence with uncertainty. The family planning 
estimation model produces projections for contraceptive 
prevalence that are informed by the most recent levels of 
the indicator, as well as by the historical trends. In some 
cases the effect of the historical trend results in changes 
between recent observations having less impact on 
current estimates and projections. We have adjusted the 
family planning estimation model to correct for this, 
the details of which are described below. Estimates of 
unmet need were obtained by modelling the relationship 
between contraceptive prevalence and unmet need. 
Similar to the model for contraceptive prevalence, a 
hierarchical approach was used to estimate parameters 
and time-dependent distortions were added to capture 
country-specific changes in trends of unmet need.
The global family planning estimation model and 
subsequently the FPET tool were updated to address 
some limitations of the original model, specifically, to 
better capture changes in recently observed data and 
include survey sample-specific uncertainties, to 
ultimately provide more precise estimates, projections, 
and associated uncertainties. The updates can be 
summarised as follows. Time-dependent distortions 
added to the expected trend for total contraceptive 
mCPR (%) Unmet need for 
modern methods (%)
Demand satisfied with 
modern methods (%)
Afghanistan 20·9% (16·0–27·1) 27·9% (22·9–33·4) 42·7% (34·7–51·7)
Bangladesh 56·4% (46·1–65·7) 19·2% (13·7–26·3) 74·5% (64·3–82·5)
Benin 13·0% (8·0–19·6) 36·1% (28·6–44·1) 26·5% (17·4–36·8)
Bhutan 64·6% (48·1–78·9) 12·7% (6·0–23·2) 83·4% (68·0–92·8)
Bolivia 44·1% (26·7–60·4) 36·7% (23·2–53·5) 54·5% (33·5–71·9)
Burkina Faso 24·7% (21·1–28·8) 27·2% (21·6–33·6) 47·6% (40·9–55·1)
Burundi 25·2% (20·4–30·7) 33·1% (28·6–37·8) 43·2% (36·4–50·5)
Cambodia 42·8% (31·8–53·4) 28·8% (21·0–39·9) 59·8% (45·4–71·2)
Cameroon 21·8% (13·2–29·7) 33·2% (25·6–42·1) 39·6% (26·0–50·8)
Central African Republic 14·5% (6·8–27·4) 30·0% (20·6–41·5) 32·4% (17·8–51·1)
Chad 4·3% (2·7– 6·8) 22·7% (18·0–28·2) 16·0% (10·4–23·6)
Comoros 18·7% (11·1–29·4) 35·9% (28·6–44·0) 34·1% (22·1–48·0)
Congo (Brazzaville) 23·9% (14·5–35·6) 37·9% (28·3–49·1) 38·5% (24·3–54·0)
CÔte d’Ivoire 15·8% (12·1–20·0) 29·0% (22·4–36·6) 35·3% (27·6–43·6)
Democratic Republic of 
the Congo
10·0% (5·8–16·2) 39·9% (32·1–48·4) 20·0% (12·1–30·3)
Djibouti 24·3% (15·1–36·1) 30·0% (19·6–42·1) 44·7% (30·4–61·1)
Egypt 59·7% (49·3–69·5) 12·9% (8·4–18·3) 82·2% (73·3–89·1)
Eritrea 9·7% (5·2–18·2) 30·4% (21·7–40·6) 24·4% (13·8–38·8)
Ethiopia 37·5% (31·6–43·6) 23·7% (19·9–27·9) 61·2% (54·3–67·8)
Gambia 9·8% (6·0–15·3) 26·7% (20·6–33·9) 26·8% (17·6–38·2)
Ghana 27·1% (22·0–32·9) 34·0% (28·7–39·7) 44·3% (37·3–52·0)
Guinea 6·2% (3·4–10·8) 25·6% (19·5–32·8) 19·5% (11·5–30·4)
Guinea-Bissau 16·3% (9·2–26·6) 23·2% (15·6–32·6) 41·2% (26·4–57·4)
Haiti 35·4% (24·2–48·4) 35·5% (27·0–43·9) 49·8% (36·6–63·6)
Honduras 65·4% (52·8–75·8) 18·6% (11·6–28·4) 77·8% (65·4–86·6)
India 52·8% (44·8–60·7) 18·9% (14·7–24·3) 73·7% (65·8–80·0)
Indonesia 59·4% (51·6–67·0) 13·7% (9·7–18·7) 81·2% (74·1–87·1)
Iraq 43·6% (27·9–59·1) 27·4% (16·8–41·0) 61·2% (41·6–77·3)
Kenya 62·3% (54·0–69·6) 16·8% (12·4–22·3) 78·8% (71·2–84·7)
Kyrgyzstan 39·1% (27·9–51·3) 20·3% (14·8–26·5) 65·7% (53·2–76·7)
Laos 49·4% (35·7–62·2) 23·2% (15·6–32·6) 67·9% (53·3–79·8)
Lesotho 60·9% (50·6–70·4) 17·8% (12·1–24·7) 77·4% (67·6–85·1)
Liberia 23·6% (16·0–30·1) 31·5% (25·5–38·1) 42·7% (32·2–51·6)
Madagascar 39·5% (27·4–52·8) 24·9% (17·4–33·5) 61·3% (46·9–74·2)
Malawi 58·5% (50·6–66·1) 19·2% (14·6–24·3) 75·3% (67·9–81·8)
Mali 13·5% (8·7–20·1) 26·5% (20·8–33·1) 33·7% (23·6–44·9)
Mauritania 16·0% (9·9–24·4) 32·6% (24·4–41·8) 32·9% (22·0–46·0)
Mongolia 53·2% (39·8–65·6) 20·0% (12·7–29·7) 72·7% (58·5–83·3)
Mozambique 31·4% (19·7–38·1) 24·9% (20·2–30·6) 55·7% (41·3–63·9)
Myanmar 52·2% (44·9–59·2) 17·0% (13·2–21·3) 75·4% (68·4–81·4)
Nepal 50·8% (39·6–61·9) 25·9% (18·2–34·3) 66·2% (54·2–77·1)
Nicaragua 77·4% (67·3–85·0) 10·2% (6·0–16·6) 88·4% (80·4–93·4)
Niger 14·7% (10·9–19·2) 20·9% (16·2–26·6) 41·3% (32·9–50·1)
Nigeria 13·1% (9·8–17·3) 25·3% (20·6–30·7) 34·1% (26·6–42·4)
North Korea 64·3% (48·7–77·6) 16·5% (8·9–27·6) 79·6% (64·6–89·6)
Pakistan 30·6% (24·4–38·0) 29·7% (23·3–37·3) 50·8% (41·6–60·1)
Palestine 47·4% (32·8–61·6) 25·0% (15·7–37·5) 65·5% (48·1–79·2)
Papua New Guinea 28·7% (14·8–46·4) 32·1% (21·6–44·6) 46·9% (28·0–66·2)
Philippines 41·4% (30·0–53·4) 31·9% (23·5–42·1) 56·4% (42·4–69·1)
Rwanda 50·2% (41·7–58·5) 23·3% (17·9–29·3) 68·3% (59·3–76·2)
(Table 1 continues on next page)
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prevalence now capture how rates of change in the 
observed data (ie, faster or slower rates of change in 
contraceptive prevalence) deviate from the rates of 
change indicated by the expected trend. Projections are 
informed by recent changes that have occurred in 
contraceptive prevalence (ie, the difference between the 
two most recent surveys) as well as past experience 
(appendix pp 9–13). For observations that belong to the 
DHS survey source, survey-specific sampling error 
variances were computed from the corresponding 
micro-data (appendix pp 14, 15). Survey-specific sampling 
error variances were imputed for the remaining 
observations (appendix p 15). For each survey source, 
sampling variances were included in the model in 
combination with an estimated non-sampling error to 
fully account for the uncertainty in the observed data 
(appendix pp 16, 17). Information relating to the start and 
end year of when a survey was done has been included in 
the model, therefore a survey observation is no longer 
assumed to only provide information for one calendar 
year (appendix p 15).
Assessment of contraceptive use between 2012 and 2017
Estimates and projections of modern contraceptive 
prevalence, unmet need for, and demand satisfied with 
modern contraceptive methods were produced by the 
FPET for 68 FP2020 countries individually and for 
regional and overall aggregates.11 Demand satisfied was 
calculated based on the definition provided by Fabic and 
colleagues12 in 2015. In India, the FPET was applied at 
the state level and the state estimates were aggregated to 
provide national totals. Trends were analysed in terms of 
the level of the indicators and the changes that have 
been seen between 2012 and 2017. If we consider that all 
FP2020 countries have a demand for contraception, 
progress within individual countries and overall was 
deemed positive if we see an increase in mCPR and 
demand satisfied with modern methods.
Contribution of women of reproductive age who are 
married or in a union to the 120×20 goal
The number of additional users is the difference in the 
total number of modern contraceptive users between 
two points in time. Following this, estimates for 
mCPR combined with population data for women of 
reproductive age who are married or in a union13,14 
(appendix p 8) were used to determine the changes in 
the number of women using modern methods of 
contraception between 2012 and 2017. This provided an 
estimate for the number of married or in a union users 
of reproductive age who have contributed to the FP2020 
120 × 20 goal thus far.
Comparison of expected versus observed levels of mCPR 
since 2012
We quantified the progress that has been made towards 
increasing modern contraceptive use since 2012 by 
analysing a reduced input dataset (leaving out all 
observations that had a start date greater than 2012). 
The reduced input data provided counterfactual 
model-based trends that reflect pre-FP2020 expectations 
for contraceptive use (appendix pp 21, 22). By comparing 
estimates and counterfactual projections in the years 
where data were removed, we assessed whether 
progress in the FP2020 countries has been faster 
or slower than expected. We calculated attainment 
probabilities that provided a continuous measure of how 
current estimates for post-2012 observations compare 
with 2012 expectations. The attainment probabilities 
directly measure the likelihood of observing an outcome 
that is equal to or greater than the estimate based on the 
full dataset (eg, a 10% attainment probability means 
that there was a 10% chance of attaining the level 
observed based on pre-2012 expectations). This metric is 
directly comparable across all countries (the interpre-
tation is the same across countries and does not need to 
be combined with an uncertainty interval) and the 
combined set of probabilities provides an informative 
and concise summary of progress as compared with 
what was expected for all countries. When assessing 
country-specific trends, modern contraceptive use was 
deemed to have had made positive progress since the 
beginning of the FP2020 initiative in 2012 if two criteria 
were met: there was an increase in observed levels of 
mCPR compared with expected levels of mCPR; and 
expected trends indicated that the increase in mCPR had 
a low attainment probability (<50%).
mCPR (%) Unmet need for 
modern methods (%)
Demand satisfied with 
modern methods (%)
(Continued from previous page)
São Tomé and Príncipe 46·8% (33·9–60·0) 31·2% (21·5–41·2) 59·9% (45·6–73·4)
Senegal 21·7% (15·6–29·2) 26·9% (22·5–31·6) 44·6% (35·5–54·3)
Sierra Leone 19·5% (13·1–26·2) 27·1% (21·3–33·4) 41·8% (31·0–51·8)
Solomon Islands 31·2% (17·1–48·4) 27·4% (17·9–38·9) 52·7% (34·3–71·1)
Somalia 2·6% (0·7– 7·7) 31·4% (19·8–45·5) 7·8% (2·3–20·1)
South Sudan 3·6% (1·7– 8·0) 30·6% (19·9–43·2) 10·7% (4·9–22·0)
Sri Lanka 58·5% (38·5–74·7) 21·7% (11·1–39·3) 72·8% (50·5–86·8)
Sudan 13·0% (7·6–21·2) 29·4% (21·2–39·4) 30·6% (19·3–44·5)
Tajikistan 30·0% (19·6–42·8) 24·9% (18·7–32·0) 54·4% (40·8–67·8)
Timor-Leste 25·2% (20·1–31·1) 27·4% (22·9–32·1) 47·9% (40·2–55·7)
Togo 20·9% (14·8–26·2) 35·3% (29·3–41·7) 37·2% (28·3–45·1)
Uganda 34·3% (28·8–40·1) 33·2% (28·7–38·0) 50·7% (44·1–57·6)
Tanzania 34·9% (27·4–42·3) 27·8% (22·8–33·5) 55·6% (46·2–64·1)
Uzbekistan 65·7% (47·0–80·8) 12·6% (5·9–22·9) 83·8% (68·1–93·0)
Vietnam 66·3% (55·6–75·5) 17·4% (11·0–26·6) 79·2% (68·0–87·1)
Yemen 33·6% (23·8–45·4) 31·8% (24·5–39·3) 51·3% (39·2–64·0)
Zambia 48·2% (37·2–59·7) 23·6% (17·0–30·8) 67·1% (55·5–77·5)
Zimbabwe 66·3% (56·1–73·0) 11·9% (8·0–18·0) 84·7% (76·2–89·9)
Data in parentheses are 95% uncertainty intervals.
Table 1: Modern contraceptive prevalence rate (mCPR), unmet need for modern methods, and demand 
satisfied with modern methods in 2017 for 68 Family Planning 2020 countries
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Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all data in the 
study and had final responsibility for the decision to 
submit for publication.
Results
Modelled estimates and projections for all FP2020 
countries, regional aggregates, and an all-country 
aggregate are shown in the appendix (pp 25–112) for the 
three indicators, mCPR, unmet need for, and demand 
satisfied with modern contraceptive methods. An 
overview of the current median levels of these three 
indicators at the country level is shown in figure 1. In 
2017, mCPR ranges from 2·6% (95% uncertainty interval 
[UI] 0·7–7·7) in Somalia to 77·4% (67·3–85·0) in 
Nicaragua (table 1). As well as having the highest levels 
of mCPR in 2017, Nicaragua had the best performance 
in terms of other indicators (unmet need for modern 
methods was 10·2% [95% UI 6·0–16·6] and the demand 
satisfied with modern methods was 88·4% [80·4–93·4]). 
By contrast, the Democratic Republic of the Congo had 
the highest unmet need for modern methods in 2017 of 
39·9% (95% UI 32·1–48·4) and Somalia had the lowest 
demand satisfied of 7·8% (2·3–20·1).
Figure 2 and the appendix (p 24) provides aggregate 
estimates of mCPR, unmet need for, and demand satisfied 
with modern methods in 2012 and 2017. Overall, in the 
FP2020 countries in 2017, mCPR was 45·7% (95% UI 
42·4–49·1) and demand satisfied with modern methods 
was 67·9% (64·4–71·1). Unmet need for modern methods 
was estimated to be 21·6% (95% UI 19·7–23·9) in the 
same year. At the regional level, Asia, which includes the 
most highly populated countries in the initiative, has seen 
mCPR among women of reproductive age who are married 
or in a union grow from 51·0% (95% UI 48·5–53·4) to 
51·8% (47·3–56·5) between 2012 and 2017. This is relatively 
slow growth compared with a change from 23·9% (95% UI 
22·9–25·0) to 28·5% (26·8–30·2) across all of Africa. 
Within the African sub-regions that have more than one 
FP2020 country, the fastest growth occurred in east Africa 
with an increase in mCPR from 32·2% (95% UI 
30·5–34·0) to 39·5% (37·0–42·0) between 2012 and 2017. 
In terms of additional users of modern methods, in 2017, 
women of reproductive age who are married or in a union 
in FP2020 countries have contributed 28·8 million 
(95% UI 5·8–52·5) to the 120 × 20 target.
Figure 2: Aggregate estimates for 2012–17 of family planning indicators
Percentage of women of reproductive age who are married or in a union (A) who use (mCPR), (B) have an unmet need for, or (C) have demand satisfied with, modern methods of contraception. 
Estimates and 95% uncertainty intervals are shown for all Family Planning 2020 countries combined and for the country subregions. mCPR=modern contraceptive prevalence.
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Change in mCPR 
(percentage points)
Change in unmet need for 
modern methods 
(percentage points)
Change in demand 
satisfied with modern 
methods (percentage 
points)
Change in the number of women 
of reproductive age who are 
married or in a union using 
modern contraception (millions)
Afghanistan* 4·5 (–1·3 to 11·1) –0·3 (–6·6 to 5·8) 5·9 (–3·6 to 15·7) 0·37 (0·08 to 0·71)
Bangladesh* 2·8 (–7·9 to 13·1) –1·4 (–7·6 to 5·8) 2·4 (–8·2 to 11·3) 2·11 (–1·76 to 5·82)
Benin* 4·6 (–0·4 to 11·1) –1·4 (–8·3 to 5·8) 8·2 (–0·7 to 18·2) 0·10 (0·01 to 0·21)
Bhutan 3·7 (–8·2 to 14·6) –1·6 (–7·4 to 5·0) 2·6 (–7·4 to 11·0) 0·02 (0·00 to 0·03)
Bolivia 4·3 (–8·6 to 17·3) –3·9 (–15·2 to 7·8) 5·1 (–9·8 to 19·3) 0·11 (–0·08 to 0·30)
Burkina Faso* 7·5 (2·0 to 13·0) –0·2 (–5·7 to 5·4) 9·0 (0·3 to 17·8) 0·32 (0·15 to 0·49)
Burundi*† –1·8 (–7·3 to 4·2) 1·0 (–4·3 to 6·4) –2·5 (–10·3 to 5·2) 0·04 (–0·05 to 0·13)
Cambodia* 5·3 (–6·7 to 17·0) –2·3 (–10·7 to 7·9) 5·0 (–9·2 to 17·8) 0·22 (–0·10 to 0·54)
Cameroon* 6·1 (–2·4 to 14·3) –0·6 (–7·8 to 7·0) 7·9 (–5·0 to 19·6) 0·29 (–0·02 to 0·59)
Central African Republic 3·0 (–2·9 to 12·5) –0·2 (–6·9 to 6·9) 5·0 (–6·0 to 18·1) 0·04 (–0·02 to 0·14)
Chad* 1·5 (–0·2 to 3·9) 0·6 (–5·0 to 6·4) 4·8 (–1·3 to 12·2) 0·05 (0·01 to 0·11)
Comoros 3·9 (–3·2 to 14·0) –1·1 (–7·8 to 6·1) 5·6 (–5·4 to 18·5) 0·01 (0·00 to 0·02)
Congo (Brazzaville)* 3·5 (–5·7 to 14·9) –3·2 (–12·2 to 6·3) 5·4 (–8·1 to 20·2) 0·04 (–0·02 to 0·11)
CÔte d’Ivoire* 3·2 (–0·9 to 7·8)  0·4 (–5·5 to 7·3) 4·8 (–3·2 to 12·9) 0·10 (–0·04 to 0·26)
Democratic Republic of the 
Congo*
2·3 (–2·5 to 8·9) –0·4 (–8·1 to 7·9) 4·2 (–4·8 to 14·5) 0·43 (–0·19 to 1·27)
Djibouti 5·1 (–3·5 to 16·2) –1·2 (–8·4 to 5·6) 6·5 (–6·1 to 19·6) 0·01 (0·00 to 0·02)
Egypt* 0·9 (–11·2 to 12·6) –0·1 (–5·7 to 5·7) 0·4 (–9·4 to 9·1) 1·03 (–0·96 to 2·95)
Eritrea 2·0 (–1·8 to 8·7) 0·3 (–6·3 to 7·3) 3·8 (–4·9 to 14·8) 0·02 (–0·01 to 0·08)
Ethiopia* 6·9 (–0·7 to 14·3) –3·3 (–8·1 to 1·7) 8·1 (–0·7 to 16·6) 1·66 (0·58 to 2·76)
Gambia* 0·7 (–3·3 to 6·3) 0·3 (–5·7 to 6·5) 1·3 (–8·2 to 12·1) 0·01 (–0·01 to 0·02)
Ghana* 5·0 (–2·0 to 12·4) –3·3 (–9·7 to 3·1) 7·1 (–2·1 to 16·7) 0·28 (0·00 to 0·58)
Guinea 1·3 (–1·4 to 5·7) 0·8 (–4·9 to 7·4) 3·1 (–4·4 to 13·0) 0·04 (–0·02 to 0·13)
Guinea-Bissau* 3·1 (–3·1 to 11·6) 0·8 (–4·8 to 6·5) 4·1 (–7·5 to 16·5) 0·01 (0·00 to 0·03)
Haiti 4·3 (–6·4 to 16·4) –3·2 (–11·1 to 4·6) 5·1 (–7·1 to 18·1) 0·13 (–0·06 to 0·34)
Honduras 1·5 (–10·0 to 11·3) –1·2 (–7·8 to 7·6) 1·5 (–9·7 to 9·8) 0·11 (–0·05 to 0·23)
India* 0·1 (–8·6 to 9·0) –0·8 (–5·8 to 4·8) 0·8 (–7·5 to 8·3) 6·39 (–15·53 to 29·01)
Indonesia* –1·1 (–9·1 to 6·8) 0·6 (–3·4 to 5·4) –0·9 (–7·9 to 5·0) 0·43 (–3·65 to 4·38)
Iraq 3·4 (–8·8 to 15·6) –1·2 (–9·8 to 8·5) 2·9 (–11·6 to 15·5) 0·49 (–0·22 to 1·17)
Kenya* 12·7 (2·3 to 22·5) –7·8 (–14·1 to –1·1) 11·9 (2·1 to 20·9) 1·26 (0·58 to 1·89)
Kyrgyzstan* 4·1 (–6·8 to 16·1) –0·6 (–5·9 to 5·1) 3·1 (–9·1 to 14·0) 0·06 (–0·06 to 0·18)
Laos 5·4 (–6·7 to 17·0) –2·7 (–9·6 to 5·3) 5·0 (–7·6 to 15·5) 0·15 (–0·02 to 0·31)
Lesotho* 7·4 (–3·9 to 18·3) –4·3 (–11·0 to 3·3) 6·6 (–4·2 to 16·1) 0·03 (0·00 to 0·05)
Liberia* 6·5 (–1·7 to 13·9) –1·7 (–8·0 to 5·0) 8·9 (–2·6 to 18·9) 0·05 (0·00 to 0·10)
Madagascar 6·2 (–5·1 to 18·5) –2·3 (–9·2 to 5·1) 6·2 (–7·0 to 18·5) 0·45 (–0·03 to 0·98)
Malawi* 9·7 (–0·5 to 19·6) –6·1 (–12·6 to 0·4) 9·5 (–0·4 to 18·9) 0·48 (0·21 to 0·73)
Mali* 3·6 (–1·3 to 10·0) –0·2 (–6·0 to 5·6) 6·7 (–3·2 to 17·6) 0·16 (0·00 to 0·37)
Mauritania* 4·3 (–1·5 to 11·8) –0·4 (–7·2 to 6·3) 6·7 (–2·9 to 17·5) 0·03 (0·00 to 0·08)
Mongolia* 2·5 (–9·5 to 14·0) –1·0 (–7·7 to 6·6) 2·0 (–9·9 to 11·8) 0·02 (–0·04 to 0·08)
Mozambique* 15·7 (4·6 to 23·0) –2·5 (–7·9 to 3·3) 19·2 (5·5 to 28·7) 0·77 (0·28 to 1·09)
Myanmar* 5·9 (–4·9 to 16·5) –2·5 (–8·4 to 3·4) 5·2 (–5·0 to 15·5) 0·61 (–0·32 to 1·53)
Nepal* 5·4 (–5·7 to 16·3) –4·4 (–11·9 to 3·5) 6·2 (–5·5 to 17·0) 0·62 (–0·06 to 1·28)
Nicaragua 0·7 (–8·7 to 7·8) –0·4 (–4·4 to 5·2) 0·5 (–6·6 to 5·2) 0·06 (–0·04 to 0·13)
Niger* 2·6 (–1·4 to 7·3) 2·2 (–2·1 to 7·4) 1·9 (–6·6 to 10·9) 0·20 (0·04 to 0·40)
Nigeria*  2·7 (–0·9 to 7·1) 2·8 (–2·3 to 8·2) 2·4 (–5·5 to 11·0) 1·11 (0·06 to 2·42)
North Korea 1·1 (–10·1 to 11·1) –0·7 (–6·9 to 6·7) 1·0 (–9·3 to 9·2) 0·02 (–0·47 to 0·45)
Pakistan* 5·2 (–2·2 to 13·1) –0·9 (–7·3 to 6·1) 5·4 (–4·8 to 15·5) 2·45 (0·16 to 4·95)
Palestine* 2·5 (–9·3 to 14·9) –0·8 (–8·9 to 8·3) 2·0 (–11·3 to 14·2) 0·05 (–0·02 to 0·12)
Papua New Guinea 1·9 (–8·0 to 13·7) –1·0 (–8·8 to 6·3) 2·4 (–10·1 to 15·7) 0·06 (–0·07 to 0·22)
Philippines* 4·1 (–7·7 to 16·5) –2·4 (–11·1 to 7·5) 4·3 (–9·8 to 17·2) 1·12 (–0·77 to 3·12)
(Table 2 continues on next page)
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Of the 47 countries that have data after 2012, based on 
median estimates, 44 countries had an increase in mCPR 
and demand satisfied in the period between 2012 and 
2017 (table 2). Mozambique and Kenya had the largest 
positive changes, with an increase in mCPR of 15·7% 
(95% UI 4·6–23·0) in Mozambique and 12·7% 
(2·3–22·5) in Kenya over the 5 years (figure 3). In 
absolute numbers, the increase in mCPR in Kenya 
translates to an additional 1·26 million (95% UI 
0·58–1·89) women of reproductive age who are married 
or in a union using modern methods of contraception 
(table 2). Conversely, mCPR and demand satisfied have 
declined in Vietnam, Indonesia, and Burundi in the 
5 years since the introduction of FP2020, with the largest 
decrease in these indicators occurring in Burundi 
(mCPR, 1·8 percentage points [95% UI –4·2 to 7·3]; 
demand satisfied, 2·5 percentage points [–5·2 to 10·3]). 
The 2012 national survey appears to be a high outlier 
relative to other datapoints in Burundi. Without this 
survey included, Burundi had an increase in mCPR of 
4·5 percentage points (95% UI –1·8 to 11·1) between 
2012 and 2017. In terms of unmet need, 37 countries had 
a decrease between 2012 and 2017 with Kenya making 
the most progress and decreasing unmet need by 
7·8 percentage points (95% UI 1·1 to 14·1) in 5 years, 
followed by Malawi with a drop of 6·1 percentage points 
(–0·4 to 12·6) over the same period. Of the countries that 
have seen an increase in unmet need, Nigeria had the 
largest increase of 2·8 percentage points (–2·3 to 8·2).
Table 3 shows the counterfactual analysis of changes in 
mCPR since 2012. The counterfactual analysis is presented 
for the 47 countries with data after 2012, 33 of which 
have made commitments to FP2020 (appendix p 5). The 
distribution of FP2020 commitment countries versus 
non-commitment countries shown in figure 4 shows that 
overall, 27 (57%) countries had levels of mCPR greater 
than or equal to pre-FP2020 expectations (ie, in 2012 the 
probability that they would reach current levels of mCPR 
was ≤50%), including 20 (61%) of the commitment 
countries in the analysis. The distribution also shows that 
12 (26%) countries reached levels of mCPR that had less 
than or equal to  25% probability of attainment pre-FP2020. 
Conversely, only two (4%) dropped to levels of mCPR 
that had greater than 75% probability of attainment 
pre-FP2020. Among the countries that we consider to 
have made the most progress relative to what was expected 
are Chad, Sierra Leone, Mozambique, and Kenya, of 
which the latter three have made commitments to FP2020. 
These four countries attained levels of mCPR post-2012 
that had a less than 10% chance of being observed 
pre-FP2020. In Kenya, the estimate for mCPR in 2015, the 
most recent observation year was 14·3 percentage points 
Change in mCPR 
(percentage points)
Change in unmet need for 
modern methods 
(percentage points)
Change in demand 
satisfied with modern 
methods (percentage 
points)
Change in the number of women 
of reproductive age who are 
married or in a union using 
modern contraception (millions)
(Continued from previous page)
Rwanda* 4·5 (–5·5 to 14·3) –3·6 (–10·0 to 3·2) 5·4 (–5·1 to 15·0) 0·14 (–0·01 to 0·29)
São Tomé and Príncipe* 6·0 (–6·0 to 17·6) –5·0 (–13·5 to 4·0) 7·1 (–5·8 to 18·9) 0·00 (0·00 to 0·01)
Senegal* 6·4 (0·0 to 14·3) –3·0 (–8·2 to 2·4) 10·8 (0·9 to 21·2) 0·20 (0·05 to 0·40)
Sierra Leone* 6·4 (–0·4 to 13·5) –0·4 (–6·3 to 5·8) 9·5 (–1·7 to 20·3) 0·08 (0·01 to 0·15)
Solomon Islands 1·8 (–8·5 to 13·6) –0·4 (–7·4 to 6·4) 1·7 (–11·1 to 14·5) 0·00 (–0·01 to 0·02)
Somalia 0·7 (–0·4 to 3·9) 0·2 (–6·9 to 7·5) 1·8 (–1·5 to 9·2) 0·01 (0·00 to 0·06)
South Sudan 0·8 (–0·7 to 4·1) 0·4 (–6·5 to 7·4) 2·2 (–2·3 to 10·0) 0·03 (0·00 to 0·10)
Sri Lanka 1·9 (–11·0 to 14·3) –1·1 (–10·7 to 9·4) 1·6 (–11·9 to 14·0) 0·05 (–0·39 to 0·48)
Sudan* 2·3 (–2·9 to 9·3) 0·1 (–6·5 to 6·7) 3·9 (–6·2 to 14·7) 0·20 (–0·11 to 0·65)
Tajikistan 3·5 (–6·6 to 15·5) –0·5 (–6·2 to 5·5) 3·4 (–9·5 to 15·8) 0·09 (–0·07 to 0·28)
Timor-Leste* 3·1 (–4·1 to 10·2) –1·7 (–7·1 to 3·7) 4·7 (–5·0 to 14·5) 0·00 (–0·01 to 0·01)
Togo* 4·6 (–2·2 to 11·1) –1·9 (–8·2 to 4·9) 6·8 (–3·1 to 15·9) 0·08 (0·00 to 0·16)
Uganda* 7·3 (0·0 to 14·5) –4·1 (–9·6 to 1·5) 8·8 (0·0 to 17·5) 0·66 (0·27 to 1·04)
Tanzania* 5·4 (–3·8 to 14·6) –2·3 (–8·2 to 3·7) 6·2 (–4·8 to 16·6) 0·72 (0·03 to 1·42)
Uzbekistan 1·2 (–10·3 to 11·6) –0·4 (–5·7 to 5·7) 0·6 (–8·5 to 8·3) 0·30 (–0·35 to 0·89)
Vietnam* –0·2 (–11·2 to 9·3)  0·4 (–6·1 to 9·4) –0·5 (–11·4 to 7·7) 0·59 (–1·49 to 2·37)
Yemen 5·4 (–5·4 to 17·3) –2·2 (–9·5 to 5·3) 5·8 (–7·0 to 19·2) 0·40 (–0·05 to 0·90)
Zambia* 6·3 (–6·0 to 18·4) –3·9 (–11·1 to 3·8) 6·6 (–5·8 to 18·3) 0·29 (0·01 to 0·56)
Zimbabwe* 5·6 (–4·3 to 14·1) –2·7 (–7·2 to 3·0)  4·2 (–4·2 to 10·8) 0·35 (0·08 to 0·56)
Data in parentheses are 95% uncertainty intervals (UIs). *Country with survey or service statistics data available after 2012. †Results for Burundi excluding the 2012 national 
survey: change in mCPR, 4·5 (95% UI –1·8 to 11·1); change in unmet need, –1·0 (–6·7 to 4·7); change in demand satisfied, 5·6 (–3·1 to 14·3); and change in number of women 
using modern contraception, 0·12 million (0·02 to 0·22).
Table 2: Changes between 2012 and 2017 in the modern contraceptive prevalence rate (mCPR), unmet need for modern methods, demand satisfied with 
modern methods, and the number of women of reproductive age who are married or in a union using modern methods of contraception 
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higher than the pre-FP2020 expectations for this year. 
This estimate equates to an additional 0·92 million 
women of reproductive age who are married or in a union 
using modern methods of contraception in 2015 compared 
with what was expected. Conversely, Burundi, which is a 
commitment country and Gambia, a non-commitment 
country, had lower levels of mCPR relative to expectations 
with a greater than 90% chance that the mCPR would be 
higher than current estimates. In terms of absolute 
numbers, the drop in mCPR in Burundi in 2016 relative to 
Figure 3: Changes in family planning indicators between 2012 and 2017
Estimated changes in (A) modern contraceptive prevalence (mCPR), (B) unmet need for, and (C) demand satisfied with modern methods between 2012 and 2017 for 47 Family Planning 2020 countries 
that have data after 2012. Horizontal lines are the 95% uncertainty intervals. Countries are ordered by decreasing point estimate. The dashed grey line indicates 0 percentage point change.
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what was expected equates to 0·15 million women of 
reproductive age who are married or in a union not using 
modern methods of contraception. Excluding the 2012 
national survey from the counterfactual analysis for 
Burundi still results in the 2016 estimate for mCPR being 
lower than 2012 expectations; however without this survey 
the median difference would be 1·3 percentage points 
rather than 9·5 percentage points.
Discussion
At the regional level, median mCPR growth across Asian 
countries has been less than 1·0 percentage point since 
2012. The more positive FP2020 results are occurring 
across the African continent where much of the overall 
increase in population between now and 2050 is 
projected to occur.15 Since 2012, mCPR in Africa has 
increased from 23·9% (95% UI 22·9–25·0) in 2012 to 
28·5% (26·8–30·2) in 2017, with the fastest growth 
occurring in east Africa. In particular for east Africa, 
Mozambique and Kenya, both of which have made 
commitments to FP2020, can be seen to have made 
the most progress of all the countries in the initiative 
both in terms of increasing mCPR and demand 
satisfied and exceeding pre-FP2020 expectations. Within 
west Africa, Nigeria, which currently has the most 
rapidly growing population among the ten largest 
countries in the world,15 has seen a change in mCPR of 
2·7 percentage points (95% UI –0·9 to 7·1) between 
2012 and 2017 (0·54 points per year; table 1).
Kenya stood out both in terms of reducing unmet 
need, increasing mCPR, and exceeding pre-FP2020 
expectations and can provide a case study for achieving 
success in other countries. For example, it is likely that 
the success in Kenya can be partly attributed to Tupange, 
a programme to scale up family planning services 
by integrating family planning into existing health 
services and working with Kenyan health officials 
and community groups.16 The programme ran up to 
2014 and implemented tools such as commodity security 
and service delivery to improve the availability of family 
planning commodities as service delivery points and to 
improve service provider capacity, quality of service, and 
choice of methods to the lowest level of health care.
In this analysis, the FPET provided probabilistic 
estimates and projections allowing us to assess the current 
levels of key FP2020 indicators, as well as current and 
future progress, with uncertainty quantification. The 
objective of this analysis was not to undertake a rigorous 
impact evaluation of the FP2020 global initiative, as the 
degree to which family planning programmes can affect 
the pace of growth in mCPR is difficult to quantify and 
will depend on a number of factors. Such factors might 
include the amount of exposure people are receiving 
towards family planning within a country, whether the 
exposure was positive and resulted in an adoption of a 
family planning method and hence resulted in mCPR 
growth, and the willingness of people to communicate 
Year of most 
recent data
Estimated mCPR 
(%)—pre-FP2020 
expectation for 
mCPR (%)*
Estimated number 
of women using 
modern methods 
(millions)—
pre-FP2020 
expectation for the 
number of women 
using modern 
methods 
(millions)†
Attainment 
probability 
for 
estimated 
mCPR (%)‡
Country 
commitment 
to FP2020
≤25% attainment probability
Mozambique 2016 14·1 0·61 0 Yes
Kenya 2015 14·3 0·92 2 Yes
Sierra Leone 2016 7·7 0·08 3 Yes
Chad 2014 1·4 0·03 7 No
Liberia 2016 7·7 0·05 10 Yes
Lesotho 2014 7·5 0·02 11 No
Malawi 2015 8·4 0·21 11 Yes
Senegal 2015 3·2 0·08 15 Yes
Zimbabwe 2016 5·2 0·13 18 Yes
Burkina Faso 2017 4·6 0·15 19 Yes
São Tomé and 
Príncipe
2014 5·7 0·00 22 No
Benin 2015 1·5 0·03 25 Yes
26–74% attainment probability
Mali 2015 1·5 0·05 26 Yes
Mauritania 2015 1·8 0·01 32 Yes
Zambia 2013 3·4 0·07 32 Yes
Cameroon 2016 1·5 0·05 36 Yes
Ethiopia 2016 2·1 0·31 38 Yes
Kyrgyzstan 2014 1·3 0·01 38 No
Palestine 2014 1·2 0·01 43 No
Myanmar 2016 1·1 0·10 44 Yes
Guinea-Bissau 2014 0·5 0·00 45 No
Togo 2016 0·3 0·00 45 Yes
Afghanistan 2016 0·3 0·02 47 Yes
Philippines 2013 0·3 0·05 47 Yes
Ghana 2016 0·2 0·01 49 Yes
Uganda 2016 0·1 0·01 49 Yes
Sudan 2014 0·0 0·00 50 No
Nigeria 2017 –0·2 –0·05 51 Yes
Nepal 2015 –0·4 –0·02 53 Yes
Pakistan 2016 –0·1 –0·02 53 No
Niger 2016 –0·4 –0·01 54 Yes
Côte d’Ivoire 2016 –0·6 –0·02 56 Yes
Tanzania 2016 –1·4 –0·11 57 Yes
Cambodia 2014 –1·2 –0·03 58 No
India 2016 –1·5 –3·69 58 Yes
Yemen 2013 –1·7 –0·07 58 No
Bangladesh 2014 –1·0 –0·37 59 Yes
Vietnam 2014 –0·7 –0·12 60 Yes
Mongolia 2013 –1·9 –0·01 63 No
Rwanda 2016 –2·3 –0·03 63 Yes
Timor-Leste 2016 –2·9 0·00 67 No
Congo 
(Brazzaville)
2014 –2·0 –0·01 68 No
(Table 3 continues on next page)
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new information and positive experiences to promote 
further growth. Providing answers to these questions 
would involve a different analytical design to what we 
have presented here, as well as the inclusion of a 
more comprehensive set of explanatory indicators 
and covariates. The purpose of this study was to show 
the advantage of using a statistical approach and the 
information that can be obtained by estimating and 
projecting trends for key FP2020 indicators at the 
aggregate and country levels. At the country level, using 
FPET estimates, we have determined the countries that 
have seen positive changes since the beginning of FP2020 
as well as the countries that appear to be lagging behind. 
Furthermore, pre-FP2020 counterfactual projections 
allowed us to highlight the countries that have exceeded 
pre-FP2020 expectations. This resulted in highlighting 
countries such as Chad. In Chad, a focus on the increase 
in mCPR alone (which is relatively small) would not 
reflect that this increase was greater than expected based 
on past trends. An area for future work is an assessment 
of the contribution of specific contraceptive methods to 
changes in mCPR to provide insight into what methods in 
particular are driving the changes.
The analysis is not without limitations, particularly with 
respect to the availability of recent data. 21 of the 
68 countries in this analysis lack any survey or service 
statistics data (or both) after 2012 resulting in less 
information to inform projections. For a country without 
recent data, projections become more reliant on past 
experience as well as on past experiences in other nearby 
countries (appendix p 12). Hence, current estimates in 
these countries are subject to change due to the addition of 
new data as well as due to possible model changes. Of the 
47 countries that have data after 2012, two are relying only 
on service statistics rather than surveys or a combination 
of both to inform recent trends. Further more, surveys 
including the DHS and PMA2020 are subject to non-
sampling error17,18 and future analysis is necessary to better 
understand the direction and size of such errors in diverse 
settings. The lack of recent data and uncertainty associated 
with available data results in uncertainty surrounding the 
estimates that might be substantial. This is true in 
particular for the uncertainty associated with additional 
users (which is based on changes in mCPR), which 
depends on the uncertainty associated with recent mCPR 
levels. In addition to data limitations, we recognise that 
producing national estimates of family planning indicators 
might mask diversity at the subnational level, particularly 
in highly populated countries such as Nigeria and India. 
However, with the exception of India (for reasons stated 
below) progress for FP2020 is currently only monitored at 
a national level. Lastly, in this study we focus only on 
women who are married or in a union. The upcoming 
FP2020 2017 report19 will present progress for all women in 
the FP2020 countries.
In India, which accounts for more than 40% of all 
modern method users in the 69 FP2020 countries, we 
had the ability to apply the FPET at the state level and 
provide national totals that reflect changes in sub-
national trends.20 In 2015–16, the fourth round of NFHS 
was done covering around 800 000 men and women. 
The preliminary results showed substantial declines of 
up to 15 percentage points in mCPR for several states 
including Gujarat, Bihar, Arunachal Pradesh, Karnataka, 
and Madhya Pradesh. Since the full datasets have not yet 
been released it is difficult to understand if the declines 
Year of most 
recent data
Estimated mCPR 
(%)—pre-FP2020 
expectation for 
mCPR (%)*
Estimated number 
of women using 
modern methods 
(millions)—
pre-FP2020 
expectation for the 
number of women 
using modern 
methods 
(millions)†
Attainment 
probability 
for 
estimated 
mCPR (%)‡
Country 
commitment 
to FP2020
(Continued from previous page)
Egypt 2014 –4·0 –0·64 72 No
Democratic 
Republic of the 
Congo
2013 –1·6 –0·19 74 Yes
Indonesia 2015 –3·2 –1·59 74 Yes
≥75% attainment probability
Burundi 2016 –9·5 –0·15 96 Yes
Gambia 2013 –6·2 –0·02 97 No
Countries are listed according to increasing attainment probability. *Difference between the current point estimate for 
mCPR and the counterfactual point estimate for mCPR (pre-FP2020 expectation) in the most recent observation year. 
†Difference between the current point estimate for the number of married or in union women aged between 15 and 
49 years using modern methods of contraception and the counterfactual point estimate (pre-FP2020 expectation) in 
the most recent observation year. ‡Pre-FP2020 probabilities of attaining the current estimates of mCPR for the most 
recent observation year.
Table 3: Results of a counterfactual analysis of changes in modern contraceptive prevalence rate (mCPR) 
since 2012
Figure 4: Attainment probabilities for modern contraceptive prevalence 
(mCPR) estimates in the most recent observation year for countries that 
made a commitment or not to FP2020 
Results are for countries that had data available after 2012. 
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are real or due to methodological problems. The 
situation was reviewed at a meeting of national technical 
experts in New Delhi in April, 2017.21 The experts 
recommended that, until the datasets are released, the 
NFHS-4 results should be excluded from the estimates 
for any state in which they fall outside 2 SDs from the 
projected mCPR trend for 2016. Given how important 
trends in India are to the aggregate trends for all 
countries, we have heeded this advice. Thus, the India 
national aggregate estimates of family planning 
indicators include NFHS-4 results for all states except 
four of the five mentioned above. For Bihar, the 
NFHS-4 result was included along with the estimates 
from the Bihar national survey of women of reproductive 
age who are married or in a union and the Sector Wide 
Approach to Strengthen Health Survey, 2015–16. The 
estimates will be revised once the final datasets are 
released and final estimates can be studied in detail.
It remains to be seen if the FP2020 initiative will achieve 
its 120 × 20 goal. Our results show that progress is being 
made for women of reproductive age who are married or 
in a union, who make up almost three quarters of the 
total number of additional users of modern methods 
of contraception estimated between 2012 and 2017 at 
38·8 million,19 but the rate of change is not as fast as 
desired. However, we know that secular changes in 
behaviours like contraceptive use across vast populations 
do not change rapidly over an 8 year period. We recognise 
that the animation of the international family planning 
field after the London Summit in 2012 did not immediately 
result in implementation of new programmes and 
new interventions. Rather, the global family planning 
community has arguably still not assembled the critical 
mass of new programmes, policies, and interventions in 
the field that are commensurate with the ambitious 
120 × 20 goal. Additionally, despite funding pledges, 
funding has probably not increased substantially since 
2012, as is suggested in the recent FP2020 report19 and is 
inadequate.22 Analyses such as those we have presented 
here can serve to re-ignite commitment toward achieving 
the 120 × 20 goal and place focus on the countries and 
regions where intervention is needed the most. At the 
follow-up London Family Planning Summit of 
July 11, 2017, policy makers, countries, donors, civil 
society, and the private sector committed new resources 
to the effort, and the overall mediocre estimates of 
progress has the potential to be offset by a renewed 
energy and commitment directed toward FP2020 at 
global and country levels.23
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